Recombinant Human OTUD7B Protein，His

OTUD7B, a member of the ovarian tumor domain-containing deubiquitinating enzyme family, has garnered considerable interest in the field of molecular biology and cancer research due to its role in regulating protein ubiquitination, a crucial post-translational modification that influences various cellular processes, including signal transduction, cell cycle progression, and apoptosis. Dysregulation of ubiquitin pathways is often implicated in cancer development and progression, making OTUD7B a potential therapeutic target. Studies have demonstrated that OTUD7B can remove ubiquitin chains from substrate proteins, thereby stabilizing key regulatory proteins and modulating cellular responses to stress and inflammation. Recent research has unveiled its involvement in the regulation of immune responses and its potential role in the pathogenesis of several diseases, including cancers such as breast and lung cancer. Understanding the enzymatic activity and substrate specificity of OTUD7B is essential for elucidating its functional significance in cellular homeostasis and disease. Consequently, the development of OTUD7B recombinant proteins has emerged as a crucial tool for investigating its molecular mechanisms and exploring its therapeutic potential, paving the way for groundbreaking advances in targeted cancer therapies and biomarker discovery. This research not only enhances our understanding of OTUD7B's biological functions but also contributes to the broader knowledge of the ubiquitin-proteasome system in health and disease.